๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Lymphoma (malignant lymphoma, lymphosarcoma) in the dog

โœ Scribed by T. Rallis; A. Koutinas; S. Lekkas; C. Papadiamantis


Book ID
114874122
Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
979 KB
Volume
33
Category
Article
ISSN
0022-4510

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


In vivoandin vitroproperties of malignan
โœ Christopher L. Reading; Paul M. kraemer; Karen M. Miner; Garth L. Nicolson ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› Springer ๐ŸŒ English โš– 1022 KB

Using the RAW117 lymphoma/lymphosarcoma system syngeneic to Balb/c strain mice, variant sublines have been selected ~r enhanced blood-borne liver colonization in vivo or for lack of binding to immobilized lectins in vitro. The kinetic organ distributions of intravenously injected, 3H-thymidine-label

Cytogenetics in malignant lymphoma
โœ Robert V. Pierre ๐Ÿ“‚ Article ๐Ÿ“… 1978-1979 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 337 KB
Malignant lymphoma in childhood
โœ K. N. Sachdev; V. B. Kalra; I. N. Ramdeo; J. Sachdev ๐Ÿ“‚ Article ๐Ÿ“… 1973 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 222 KB
Mitoxantrone in malignant lymphoma
โœ Richard A. Gams; Shelley Bryan; Gary Dukart; Arnold Weiss; Delvyn Case; Stephen ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› Springer US ๐ŸŒ English โš– 237 KB

Two phase II trials of mitoxantrone (Novantrone; dihydroxyanthracenedione) in refractory malignant lymphoma have been conducted. In the first of these, mitoxantrone, 5 mg/m2, was given weekly for six weeks and in the second, 14 mg/m2 was administered every three weeks. The first trial was conducted